Tip 2 Diyabet Hastalarında İlaç Uyumu ve Etkileyen Faktörler

Abstract

Amaç: Bu çalışma klinik ve sosyo-demografik özellikler ile ilaç uyumu arasındaki ilişkiyi incelemeyi amaçlamaktadır. Gereç ve Yöntemler: Kesitsel tipteki bu nicel çalışmamıza, Ankara 29 Mayıs Devlet Hastanesi dahiliye polikliniklerine 20 Kasım 2023–20 Şubat 2024 tarihleri arasında Tip 2 diyabet kontrol muayenesi için başvuran 431 hasta katılmıştır. Dolayısıyla bu çalışmanın verileri, Ankara 29 Mayıs Devlet Hastanesi dahiliye polikliniklerine ilgili zaman diliminde muayene olmak için başvuran tip 2 diyabetli katılımcılarından elde edilen veriler ile sınırlıdır. Araştırmada veri analizlerinde tanımlayıcı istatistikler (frekans, yüzde, ortalama, standart sapma) ve farklılık testleri (varyans analizi ve t-testi) kullanılmıştır. Farklılık testleri kapsamında sosyo-demografik değişkenler ve klinik duruma ilişkin yaşam tarzı alışkanlıkları ile ilaç uyum düzeyi arasındaki anlamlı farklılıklar analiz edilmiştir. Anlamlı fark tespit edildiğinde farkların hangi gruplar arasında olduğunu tespit etmek için Post-Hoc testi kullanılmıştır. Veri analizi için SPSS 26 sürümü kullanılmıştır. Bulgular: Diyetisyene yönlendirilen hastaların ilaç uyum raporu ölçeği ortalamaları (23,9±1,74) yönlendirilmeyenlere göre daha fazladır (t= 3,07, p= 0,002). Önerilen diyete dikkat edenlerin ilaç uyum raporu ölçeği ortalamaları (24±1,60) dikkat etmeyenlere göre daha fazladır (t= 3,31, p= 0,001). Öğün atlamadığını belirten hastaların ilaç uyum raporu ölçeği ortalamaları (24±1,69) atlayanlara göre daha fazladır ve bu fark istatistiksel olarak anlamlıdır (t= -2,28, p = 0,023). Egzersiz yapan bireylerin ilaç uyumu anlamlı şekilde (F= 4,96, p=0,002) daha yüksektir. Sonuç: İlaç uyumu açısından egzersiz ve diyet gibi sağlıklı yaşam tarzı alışkanlıklarının kazandırılması önemli bir gereklilik olarak düşünülmektedir.

Keywords

• Sağlıklı yaşam tarzı
• Tip 2 diyabet
• İlaç uyumu

Medication Adherence and Affecting Factors in Type 2 Diabetes Patients

Abstract

Aim: This study aims to examine the relationship between clinical and socio-demographic characteristics and medication adherence. Material and Methods: In this cross-sectional field study, 431 patients who applied to the internal medicine outpatient clinics of Ankara 29 Mayıs State Hospital between November 20, 2023 and February 2024 for Type 2 diabetes control examination participated. Therefore, the data of this study are limited to the data obtained from participants with type 2 diabetes who applied to the internal medicine outpatient clinics of Ankara 29 Mayıs State Hospital for examination in the relevant time period. Descriptive statistics (frequency, percentage, mean, standard deviation) and difference tests (analysis of variance and t-test) were used in the data analysis of the study. Within the scope of difference tests, significant differences between socio-demographic variables and lifestyle habits related to clinical status and medication adherence levels were analyzed. When a significant difference was detected, a post-hoc test was used to determine which groups the differences were between. SPSS version 26 was used for data analysis. Results: The mean scores of the medication adherence scale of patients referred to a dietitian (23.9±1.74) were higher than those of patients who were not referred (t= 3.07, p= 0.002). The mean score on the medication adherence scale (24±1.60) of those who followed the recommended diet was higher than those who did not (t= 3.31, p= 0.001). The average score on the medication adherence scale for patients who reported not skipping meals (24±1.69) was higher than for those who did skip meals, and this difference was statistically significant (t= -2.28, p= 0.023). Medication compliance of individuals who exercise is significantly higher (F= 4.96, p=0.002). Conclusion: From the point of view of drug compliance, it is considered an important requirement to acquire healthy lifestyle habits such as exercise and diet.

Keywords

• Healthy lifestyle
• Type 2 diabetes
• Medication adherence

References

1. 1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40- 50. doi: 10.1016/j.diabres.2017.03.024.
2. 2. Mambiya M, Shang M, Wang Y, Li Q, Liu S, Yang L, Zhang Q, Zhang K, Liu M, Nie F, Zeng F, Liu W. The Play of Genes and Non-genetic Factors on Type 2 Diabetes. Front Public Health. 2019;7:349. doi: 10.3389/fpubh.2019.00349.
3. 3. World Health Organization. World Health Statistics 2016: Monitoring health for the sustainable development goals (SDGs). Geneva: World Health Organization; 2016. Available from: https://www.who.int/docs/default-source/gho-documents/ world-health-statistic-reports/world-heatlth-statistics- 2016.pdf
4. 4. International Diabetes Federation. IDF Diabetes Atlas - Tenth Edition [Internet]. 2021. p. 75-99. Available from: https://diabetesatlas. org
5. 5. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-281. doi: 10.1016/j.diabres. 2018.02.023.
6. 6. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6.
7. 7. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239-2251. doi: 10.1016/S0140- 6736(17)30058-2.
8. 8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1(Suppl 1):S62-9. doi: 10.2337/dc10-S062.

9. 9. Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab. 2010;12(4):288-98. doi: 10.1111/j.1463- 1326.2009.01160.x.
10. 10. Bhutani J, Bhutani S. Worldwide burden of diabetes. Indian J Endocrinol Metab. 2014;18(6):868-70. doi: 10.4103/2230- 8210.141388.
11. 11. Psaltopoulou T, Ilias I, Alevizaki M. The role of diet and lifestyle in primary, secondary, and tertiary diabetes prevention: a review of meta-analyses. Rev Diabet Stud. 2010;7(1):26-35. doi: 10.1900/RDS.2010.7.26.
12. 12. Abahussain NA, El-Zubier AG. Diabetes knowledge among self reported diabetic female teachers: Al-khobar, saudi arabia. J Family Community Med. 2005;12(1):43-8.
13. 13. Abbas A, Nasir H, Zehra A, Noor A, Jabbar FA, & Siddqui B. Assessment of depression as comorbidity in diabetes mellitus DM patients using beck depression inventory II (BDI II) scale. Journal of Young Pharmacists, (2015);7(3), 206.
14. 14. Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299-307. doi: 10.2147/PPA.S106821.
15. 15. Atlas D. International diabetes federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation, 2015;33(2).
16. 16. While A. Medication adherence: understanding the issues and finding solutions. British Journal of Community Nursing, 2025;25(10), 474-479.
17. 17. Sabaté E. (Ed.). Adherence to long-term therapies: evidence for action. World Health Organization 2003.
18. 18. Osterberg L, & Blaschke T. Drug therapy. New England Journal of Medicine, 2005;353(5), 487-497.
19. 19. Kardas P, Lewek P, & Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Frontiers in pharmacology, 2013;4, 91.
20. 20. Asha A, Pradeepa R, & Mohan V. Evidence for benefits from diabetes education program. International journal of diabetes in developing countries, 2004;24, 96-102.
21. 21. Kang H. Sample size determination and power analysis using the G* Power software. Journal of educational evaluation for health professions, 2021;18.
22. 22. Ko MJ, & Lim CY. General considerations for sample size estimation in animal study. Korean Journal of Anesthesiology, 2021;74(1), 23-29.
23. 23. Horne R, & Evans N. Concordance and medicines management in the respiratory arena. Newmarket, UK: Hayward Medical Communications, 2003;1-12.
24. 24. Sandy R, & Connor U. Variation in medication adherence across patient behavioral segments: a multi-country study in hypertension. Patient preference and adherence, 2015;1539- 1548.
25. 25. Sen E, Berk H, & Sindel D. The validity and reliability study of the Turkish adaptation of medical adherence report scale. Journal of Istanbul Faculty of Medıcıne-Istanbul Tıp Fakultesı Dergısı, 2019;82(1).
26. 26. Baltacı G, & Tedavi F. Obezite ve egzersiz. Sağlık Bakanlığı Yayınları, Ankara, 2018;730, 13-16.
27. 27. Pallant J. SPSS survival manual: A step by step guide to data analysis using IBM SPSS. Routledge, 2020.
28. 28. Zinbarg RE, Revelle W, Yovel I, Li W. Cronbach’s α, Revelle’s β, and McDonald’s ω H: Their relations with each other and two alternative conceptualizations of reliability. psychometrika, 2015;70, 123-133.
29. 29. Zairina E, Nugraheni G, Sulistyarini A, Mufarrihah, Setiawan CD, Kripalani S, Lestari SI. Factors related to barriers and medication adherence in patients with type 2 diabetes mellitus: a cross-sectional study. J Diabetes Metab Disord. 2022;21(1):219-228. doi: 10.1007/s40200-021-00961-6.
30. Graffigna G, Barello S, Bonanomi A. The role of Patient Health Engagement Model (PHE-model) in affecting patient activation and medication adherence: A structural equation model. PLoS One. 2017;12(6):e0179865. doi: 10.1371/journal. pone.0179865.
31. 31. Shakya P, Shrestha A, Karmacharya BM, Morisky DE, Kulseng BE. Factors Associated with Medication Adherence among Patients with Type 2 Diabetes Mellitus: A Hospital-Based Cross-Sectional Study in Nepal. Int J Environ Res Public Health. 2023;20(2):1537. doi: 10.3390/ijerph20021537.
32. 32. Kassahun T, Gesesew H, Mwanri L, Eshetie T. Diabetes related knowledge, self-care behaviours and adherence to medications among diabetic patients in Southwest Ethiopia: a cross-sectional survey. BMC Endocr Disord. 2016;16(1):28. doi: 10.1186/s12902-016-0114-x.
33. 33. Lee WY, Ahn J, Kim JH, Hong YP, Hong SK, Kim YT, Lee SH, Morisky DE. Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea. J Int Med Res. 2013;41(4):1098-110. doi: 10.1177/0300060513484433.
34. 34. Sweileh WM, Zyoud SH, Abu Nab’a RJ, Deleq MI, Enaia MI, Nassar SM, Al-Jabi SW. Influence of patients’ disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014;14:94. doi: 10.1186/1471-2458-14-94.
35. 35. Chew BH. Medication adherence on quality of life among adults with type 2 diabetes mellitus: an exploratory analysis on the EDDMQoL study. Qual Life Res. 2015;24(11):2723-31. doi: 10.1007/s11136-015-1006-7.
36. 36. Aloudah NM, Scott NW, Aljadhey HS, Araujo-Soares V, Alrubeaan KA, Watson MC. Medication adherence among patients with Type 2 diabetes: A mixed methods study. PLoS One. 2018;13(12):e0207583. doi: 10.1371/journal.pone.0207583.
37. 37. Sah BK, Basyal D, & Gaire A. Medication non-adherence among type-II diabetes mellitus out-patients attending at tertiary care hospital, Nepal. Clin Pharmacol Biopharm, 2021;1, 7.
38. 38. Ekici FS. Tip 2 Diyabetes Mellitus tanısı alan hastaların ilaç tedavisine uyumu ve yaşam kalitesi ile ilişkisi [Uzmanlık tezi]. Denizli: Pamukkale Üniversitesi Tıp Fakültesi, Aile Hekimliği Anabilim Dalı; 2021.
39. 39. de Fine Olivarius N, Siersma VD, Køster-Rasmussen R, Heitmann BL, Waldorff FB. Weight changes following the diagnosis of type 2 diabetes: the impact of recent and past weight history before diagnosis. results from the Danish Diabetes Care in General Practice (DCGP) study. PLoS One. 2015;10(4):e0122219. doi: 10.1371/journal.pone.0122219.
40. 40. Chaudhry ZW, Gannon MC, Nuttall FQ. Stability of body weight in type 2 diabetes. Diabetes Care. 2006;29(3):493-7. doi: 10.2337/diacare.29.03.06.dc05-1703.
41. 41. Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care. 1995;18(11):1415-27. doi: 10.2337/diacare.18.11.1415.
42. 42. Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani B. The importance of hypoglycemia in diabetic patients. J Diabetes Metab Disord. 2012;11(1):17. doi: 10.1186/2251-6581-11-17.
43. 43. Boyd JD, Jackson RL, & Allen JH. Avoidance of degenerative lesions in diabetes mellitus. Journal of the American Medical Association, 1942;118(9), 694-696.
44. 44. Kretchy IA, Asiedu-Danso M, & Kretchy JP. Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle-income countries. Research in social and administrative pharmacy, 2021;17(1), 2023-2026.
45. 45. Chauke GD, Nakwafila O, Chibi B, Sartorius B, Mashamba- Thompson T. Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle- income countries: A systematic scoping review. Heliyon. 2022;8(6):e09716. doi: 10.1016/j.heliyon.2022.e09716.
46. 46. Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects. A criteria-based literature review. Diabetes Care. 1997;20(9):1482-6. doi: 10.2337/diacare.20.9.1482.
47. 47. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R. Monitoring blood glucose control in diabetes mellitus: a systematic review. Health Technol Assess. 2000;4(12):i-iv, 1-93.
48. 48. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB. Tests of glycemia in diabetes. Diabetes Care. 2004;27(7):1761-73. doi: 10.2337/diacare.27.7.1761.
49. 49. Karter AJ, Ackerson LM, Darbinian JA, D’Agostino RB Jr, Ferrara A, Liu J, Selby JV. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111(1):1-9. doi: 10.1016/s0002-9343(01)00742-2.
50. 50. Acemoğlu H, Ertem M, Bahçeci M, & Tuzcu A. Tip 2 diyabetes mellituslu hastaların sağlık hizmetlerinden yararlanma düzeyleri. EAJM, 2006;38, 89-95.
51. 51. Donnelly LA, Morris AD, Evans JM; DARTS/MEMO collaboration. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM. 2007;100(6):345- 50. doi: 10.1093/qjmed/hcm031.
52. 52. Aktaş A. Tip 2 diyabetik hastalarda kapsamlı diyabet tedavisi eğitimi ve uygulamalarının glisemik kontrolün sağlanmasına etkileri. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Aile Hekimliği Koordinatörlüğü. (2008). İstanbul. Erişim tarihi, 10, 2011.
53. 53. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998;22(1):39-47. doi: 10.1038/sj.ijo.0800541.
54. 54. S A, T M. Self Care and Medication Adherence among Type 2 Diabetics in Puducherry, Southern India: A Hospital Based Study. J Clin Diagn Res. 2014;8(4):UC01-3. doi: 10.7860/ JCDR/2014/7732.4256.
55. 55. Fadare J, Olamoyegun M, Gbadegesin BA. Medication adherence and direct treatment cost among diabetes patients attending a tertiary healthcare facility in Ogbomosho, Nigeria. Malawi Med J. 2015;27(2):65-70. doi: 10.4314/mmj.v27i2.7.
56. 56. Siopis G, Colagiuri S, Allman-Farinelli M. Dietitians’ experiences and perspectives regarding access to and delivery of dietetic services for people with type 2 diabetes mellitus. Heliyon. 2020;6(2):e03344. doi: 10.1016/j.heliyon.2020.e03344.
57. 57. Crespo TS, Andrade JMO, Lelis DF, Ferreira AC, Souza JGS, Martins AMEBL, Santos SHS. Adherence to medication, physical activity and diet among older people living with diabetes mellitus: Correlation between cognitive function and health literacy. IBRO Rep. 2020;9:132-137. doi: 10.1016/j. ibror.2020.07.003.
58. 58. Aguirre F, Brown A, Cho NH, Dahlquist G, Dodd S, Dunning T, Hirst M, Hwang C, Magliano D, Patterson C, Scott C, Shaw J, Soltesz G, Usher-Smith J, & Whiting D. IDF Diabetes Atlas: Sixth edition. (Sixth ed.) International Diabetes Federation, 2013.
59. 59. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537-44. doi: 10.2337/diacare.20.4.537.
60. 60. Wong MC, Wu CH, Wang HH, Li HW, Hui EM, Lam AT, Chung RY, Yip BH, Morisky DE. Association between the 8-item Morisky medication adherence scale (MMAS-8) score and glycaemic control among Chinese diabetes patients. J Clin Pharmacol. 2015;55(3):279-87. doi: 10.1002/jcph.408.
61. 61. Benson GA, Sidebottom A, Hayes J, Miedema MD, Boucher J, Vacquier M, Sillah A, Gamam S, VanWormer JJ. Impact of ENHANCED (diEtitiaNs Helping pAtieNts CarE for Diabetes) Telemedicine Randomized Controlled Trial on Diabetes Optimal Care Outcomes in Patients with Type 2 Diabetes. J Acad Nutr Diet. 2019;119(4):585-598. doi: 10.1016/j. jand.2018.11.013.
62. 62. Özer E. Diabet Diyetisyenliği Diabette Beslenme Tedavisi. İstanbul: HÜ Beslenme ve Diyetetik Bölümü ve TDD Yayını; 1999.
63. 63. Siopis G, Colagiuri S, Allman-Farinelli M. People With Type 2 Diabetes Report Dietitians, Social Support, and Health Literacy Facilitate Their Dietary Change. J Nutr Educ Behav. 2021;53(1):43-53. doi: 10.1016/j.jneb.2020.09.003.
64. 64. Arı N, Özdelikara A. Dahiliye kliniklerine başvuran tip 2 diyabet hastalarında aile desteğinin hastalığı kabullenme ve tedavi uyumuna etkisi: Ordu ili örneği. Türkiye Diyabet Obezite Derg. 2022;6(1):39-48.
65. 65. Okur Ü, Özaydın T. Determination of factors associated with glycemic control in women with type 2 diabetes: Nutrition and physical activity level. Turk J Diabetes Obes. 2024;8(3):203- 214.
66. 66. Edelman SV, Henry RR. Diagnosis and management of type 2 diabetes. Professional Communications; 2002.
67. 67. Delahanty LM, Dalton KM, Porneala B, Chang Y, Goldman VM, Levy D, et al. Improving diabetes outcomes through lifestyle change—a randomized controlled trial. Obesity (Silver Spring). 2015;23(9):1792-9.
68. 68. Parker AR, Byham-Gray L, Denmark R, Winkle PJ. The effect of medical nutrition therapy by a registered dietitian nutritionist in patients with prediabetes participating in a randomized controlled clinical research trial. J Acad Nutr Diet. 2014;114(11):1739-48. doi: 10.1016/j.jand.2014.07.020.
69. 69. Küçük E, Yapar K. Health perception, health-related behaviors, and medication adherence of patients with Type II Diabetes: a study in the Black Sea Region of Turkey. TAF Prev Med Bull. 2016;15(4):285-292.